Clinical trial
Pilot Phase 2 Study of Intratumoral G100 in Patients With Cutaneous T Cell Lymphoma
NCT03742804 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Phase 2 Study of Intratumoral G100 in Patients With Cutaneous T Cell Lymphoma
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 30, 2019
- Completion date
- December 31, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.